期刊文献+

Clinicopathological Features of Breast Cancer with Different Molecular Subtypes in Chinese Women 被引量:7

Clinicopathological Features of Breast Cancer with Different Molecular Subtypes in Chinese Women
下载PDF
导出
摘要 A retrospective study was performed to explore the relationship between molecular subtypes and clinicopathological features of breast cancer in Chinese women. Six hundred and twenty-eight Chi- nese women with breast cancer were classified into four molecular subtypes according to their estrogen receptor (ER), progesterone receptor (PR) and Her-2 status. The prevalence rate of each molecular sub- type was analyzed. Relationship between the subtypes and clinicopathologic features was determined. The distribution of molecular subtypes was as follows: luminal A 46.5%, luminal B 17.0%, basal 21.5%, HER2/neu 15.0%. The subtypes had no significant difference under different menopausal status. How- ever, in the age-specific groups, the age group of〈35 years was more likely to get basal cell-like cancer (36.9%). Statistically significant differences were found among molecular subtypes by age, nuclear grade, tumor size, lymph node (LN) metastasis, tumor stage by American Joint Committee on Cancer (AJCC), radiotherapy but not by chemotherapy, types of surgery. After adjusting for several relative confounding factors, the basal subtype more likely had lower nodal involvement in both the incidence of LN metastasis (〉1 positive LN) and incidence of high-volume LN metastasis (〉4 positive LN). The HER2/neu subtype had higher nodal involvement in the incidence of high-volume LN metastases. After adjusting for relative confounding factors, the HER2/neu subtype more likely had higher AJCC tumor stages. It was suggested that there existed close relationship between molecular subtypes and clinicopa- thological features of breast cancer. In addition, the breast cancer subtypes have been proven to be an independent predictor of LN involvement and AJCC tumor stage. These findings are very important for understanding the occurrence, development, prognosis and treatment of breast cancer in Chinese popu-lation. A retrospective study was performed to explore the relationship between molecular subtypes and clinicopathological features of breast cancer in Chinese women. Six hundred and twenty-eight Chi- nese women with breast cancer were classified into four molecular subtypes according to their estrogen receptor (ER), progesterone receptor (PR) and Her-2 status. The prevalence rate of each molecular sub- type was analyzed. Relationship between the subtypes and clinicopathologic features was determined. The distribution of molecular subtypes was as follows: luminal A 46.5%, luminal B 17.0%, basal 21.5%, HER2/neu 15.0%. The subtypes had no significant difference under different menopausal status. How- ever, in the age-specific groups, the age group of〈35 years was more likely to get basal cell-like cancer (36.9%). Statistically significant differences were found among molecular subtypes by age, nuclear grade, tumor size, lymph node (LN) metastasis, tumor stage by American Joint Committee on Cancer (AJCC), radiotherapy but not by chemotherapy, types of surgery. After adjusting for several relative confounding factors, the basal subtype more likely had lower nodal involvement in both the incidence of LN metastasis (〉1 positive LN) and incidence of high-volume LN metastasis (〉4 positive LN). The HER2/neu subtype had higher nodal involvement in the incidence of high-volume LN metastases. After adjusting for relative confounding factors, the HER2/neu subtype more likely had higher AJCC tumor stages. It was suggested that there existed close relationship between molecular subtypes and clinicopa- thological features of breast cancer. In addition, the breast cancer subtypes have been proven to be an independent predictor of LN involvement and AJCC tumor stage. These findings are very important for understanding the occurrence, development, prognosis and treatment of breast cancer in Chinese popu-lation.
出处 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2013年第1期117-121,共5页 华中科技大学学报(医学英德文版)
关键词 breast cancer molecular subtypes clinicopathological features breast cancer molecular subtypes clinicopathological features
  • 相关文献

参考文献22

  • 1Greenlee RT,Murray T,Bolden S. Cancer statistics,2000[J].CA:A Cancer Journal for Clinicians,2000,(01):7-33.
  • 2Tavassoli FA,Schnitt SJ. Pathology of the breast[M].New York:Elsevier,1992.27-36.
  • 3Wiencke JK. Opinion:Impact of race/ethnicity on molecular pathways in human cancer[J].Nature Reviews Cancer,2004,(01):79-84.
  • 4Sorlie T,Tibshirani R,Parker J. Repeated observation of breast tumor subtypes in independent gene expression data sets[J].Proceedings of the National Academy of Sciences(USA),2003,(14):8418-8423.doi:10.1073/pnas.0932692100.
  • 5Brenton JD,Carey LA,Ahmed AA. Molecular classification and molecular forecasting of breast cancer:ready for clinical application[J].Journal of Clinical Oncology,2005,(29):7350-7360.doi:10.1200/JCO.2005.03.3845.
  • 6Nguyen PL,Taghian AG,Katz MS. Breast cancer subtype approximated by estrogen receptor,progesterone receptor,and HER-2 is associated with local and distant recurrence after breast conserving therapy[J].Journal of Clinical Oncology,2008,(14):2373-2378.
  • 7Rouzier R,Perou CM,Symmans WF. Breast cancer molecular subtypes respond differently to preoperative chemotherapy[J].Clinical Cancer Research,2005,(16):5678-5685.
  • 8Voduc KD,Cheang MCU,Tyldesley S. Breast cancer subtypes and the risk of local and regional relapse[J].Journal of Clinical Oncology,2010,(10):1684-1691.
  • 9Perou CM,Sorlie T,Eisen MB. Molecular portraits of human breast tumors[J].Nature,2000,(6797):747-752.
  • 10Sorlie T,Perou CM,Tibshirani R. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications[J].Proceedings of the National Academy of Sciences(USA),2001,(19):10869-10874.doi:10.1073/pnas.191367098.

同被引文献48

引证文献7

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部